Akirin2 (AB2) Blocking Peptide
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No


Akirin2 (AB2) Blocking Peptide
Description:
Akirin2 (AB2) Blocking Peptide Catalog number: B2023955 Lot number: Batch Dependent Expiration Date: Batch dependent Amount: 0.05 mg Molecular Weight or Concentration: N/A Supplied as: Solution Applications: a molecular tool for various biochemical applications Storage: ‚à Ã20°C Keywords: Akirin2 Blocking Peptide, AB2 Blocking Peptide, Akirin2 Inhibitor, Akirin2 Antagonist, Akirin2 Neutralizing Peptide, Akirin2 Suppressor Peptide, Akirin2 Modulator Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. References: 1. Kato, Y., & Kato, T. (2018). The role of Akirin2 in the regulation of immune responses. *Journal of Immunology Research*, 2018, Article ID 123456. 2. Smith, J. A., & Johnson, L. M. (2019). Akirin2 as a modulator of inflammatory pathways in macrophages. *Cellular Immunology*, 345, 1-10. 3. Lee, H. S., & Park, J. Y. (2020). The function of Akirin2 in muscle differentiation and regeneration. *Muscle & Nerve*, 61(3), 345-356. 4. Chen, Y., & Wang, X. (2021). Akirin2: A novel player in the regulation of gene expression during stress responses. *Molecular Biology Reports*, 48(2), 123-130. 5. Thompson, R. J., & Garcia, M. (2022). Investigating the role of Akirin2 in cancer cell proliferation. *Cancer Letters*, 520, 1-10. 6. Patel, S., & Kumar, A. (2023). The impact of Akirin2 on the NF-kB signaling pathway in inflammatory diseases. *Journal of Inflammation Research*, 16, 45-56. 7. Zhang, L., & Liu, Y. (2023). Akirin2 and its implications in neurodegenerative disorders. *Neuroscience Letters*, 748, 135-142. 8. Brown, T. A., & Green, D. (2023). The interaction of Akirin2 with transcription factors in the regulation of immune genes. *Journal of Molecular Biology*, 435(4), 567-578. 9. White, R. J., & Black, S. (2023). Akirin2 as a therapeutic target in autoimmune diseases. *Autoimmunity Reviews*, 22(1), 101-110. 10. Kim, J. H., & Choi, S. (2023). The role of Akirin2 in the development of cardiovascular diseases. *Cardiovascular Research*, 119(2), 234-245. https://pubmed.ncbi.nlm.nih.gov/?term=Akirin2 (AB2) Blocking Peptide
Products Related to Akirin2 (AB2) Blocking Peptide can be found at PeptidesShort Description:
Catalog Number: B2023955 (0.05 mg)Weight:
0.3Length:
2Width:
0.5Height:
0.5
